
Last Posted: Apr 23, 2021
- Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study.
Kim Joo Heung et al. Scientific reports 2021 11(1) 8485 - Controversies in Hereditary Cancer Management.
AlHilli Mariam M et al. Obstetrics and gynecology 2021 - Impact of national guidelines on use of BRCA1/2 germline testing, risk management advice given to women with pathogenic BRCA1/2 variants and uptake of advice.
Meiser Bettina et al. Hereditary cancer in clinical practice 2021 19(1) 24 - Familial pancreatic cancer: who should be considered for genetic testing?
Kartal Kinyas et al. Irish journal of medical science 2021 - The results of multigene panel sequencing in Slovak HBOC families.
Konecny Michal et al. Neoplasma 2021 - The ten genes for breast (and ovarian) cancer susceptibility.
Foulkes William D et al. Nature reviews. Clinical oncology 2021 3 - Gene Sequencing for Pathogenic Variants Among Adults With Breast and Ovarian Cancer in the Caribbean.
George Sophia H L et al. JAMA network open 2021 4(3) e210307 - Interventions Facilitating Family Communication of Genetic Testing Results and Cascade Screening in Hereditary Breast/Ovarian Cancer or Lynch Syndrome: A Systematic Review and Meta-Analysis.
Baroutsou Vasiliki et al. Cancers 2021 13(4) - Thai patients who fulfilled NCCN criteria for breast/ovarian cancer genetic assessment demonstrated high prevalence of germline mutations in cancer susceptibility genes: implication to Asian population testing.
Lertwilaiwittaya Pongtawat et al. Breast cancer research and treatment 2021 - Co-occurrence of germline pathogenic variants for different hereditary cancer syndromes in patients with Lynch syndrome.
Ferrer-Avargues Rosario et al. Cancer communications (London, England) 2021
More
Search Result Summary
- CDC Information (10)
- NIH Information (2)
- CDC Publications (3)
- COVID-19 (2)
- Human Genome Epidemiologic Studies (931)
- GWAS Studies (5)
- Human Genomics Translation/Implementation Studies (591)
- Genomic Tests Evidence Synthesis (54)
- Genomic Tests Guidelines (27)
- Tier-Classified Guidelines (14)
- Non-Genomics Precision Health (2)
- Pathogen Advanced Molecular Detection (0)
- State Public Health Genomics Programs (100)
- Ethical/Legal and Social Issues (ELSI) (13)
Quick Links to Other Resources
Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Oct 1, 2020
- Page last updated:Apr 26, 2021
- Content source:

